Pharmacist
View Bio
![]() |
How does Cold-EEZEŽ reduce the duration of my cold? |
![]() |
Read Suzie´s Answer |

Adolescent Study
Synergy Research Inc., an independent research organization, conducted the retrospective study comprised of more than 170,000 patient days on a student population of 378 adolescents ranging in age from 12 to 18 years. The average length of stay at Heritage School is 14 months.
The Heritage School introduced COLD-EEZEŽ lozenges to aid in the relief of the common cold in response to the high incidence of colds in 1999. COLD-EEZEŽ was administered symptomatically to treat common cold signs and symptoms in September 1999 and became standard practice at the facility in December 2000. Between December 2000 and May 2001, one dose of COLD-EEZEŽ was administered daily to the Heritage School students. Medical statistics then showed a decrease in cold episodes and the findings were reported to The Quigley Corporation.
The Heritage School Study
Started September 1999 - Ended August 2001
School Aged Resident Population aged 12-18
378 patients were evaluated
Study peer reviewed and published in
The American Journal of Theraputics,
vol. 9, no. 6 November 2002
Note: One (1) COLD-EEZEŽ lozenge provides 110% of the US RDA for zinc. Dissolving One (1) lozenge per day for an extended period of time poses little health risk. As with all medical treatments, please consult your medical practitioner prior to using COLD-EEZEŽ daily. For more safety information on COLD-EEZEŽ, click here.